![]() |
Volumn 15, Issue 6, 2001, Pages 898-902
|
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: A randomized study
a
b
c
d
e
f
g
g
h
a
|
Author keywords
Acute lymphoblastic leukemia; Continuous infusion; Daunorubicin; Toxicity
|
Indexed keywords
ANTHRACYCLINE;
ASPARAGINASE;
CARBOPLATIN;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FOLINIC ACID;
HEMOPOIETIC GROWTH FACTOR;
IDARUBICIN;
METHOTREXATE;
MITOXANTRONE;
PREDNISONE;
TIOGUANINE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADULT;
ARTICLE;
BOLUS INJECTION;
BONE MARROW SUPPRESSION;
CANCER RECURRENCE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOXICITY;
FEMALE;
GASTROINTESTINAL TOXICITY;
GRAM NEGATIVE INFECTION;
GRAM NEGATIVE SEPSIS;
HUMAN;
LEUKEMIA REMISSION;
MAJOR CLINICAL STUDY;
MALE;
MINIMAL RESIDUAL DISEASE;
NEUTROPENIA;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
TIME;
|
EID: 0034993836
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402130 Document Type: Article |
Times cited : (16)
|
References (22)
|